Clindamycin Completed Phase 2 Trials for skin rashes Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00473083Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer